BioSpace News Archive

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced that the first subject has been successfully dosed in a phase 2 clinical trial of IBI362, a glucagon-like peptide 1 receptor and glucagon receptor dual agonist in China.

Tissue engineering refers to an interdisciplinary sphere that uses combination of life sciences and engineering.

Lancets are a thin needle used to pierce the skin, primarily for diabetes. The lancet market is gaining popularity over the years and expected to grow at a staggering rate in the following years.

Cloud computing is one of the most commonly used applications in healthcare. Healthcare organizations are highly concerned about the privacy and security of patient information, and the pressure of managing the growing healthcare data has driven the implementation of cost effective solutions such as cloud computing.

The overwhelming need for novel and enhanced therapies for a variety of diseases and disorders may bring extensive growth prospects for the cell therapy technologies market during the forecast period.

The global empty IV bags segment is expected to exhibit a steady growth owing to the increasing demand for non-toxic IV bags.

Contract manufacturing is a process where the manufacturers typically engage in an agreement with different companies for product manufacturing or component manufacturing.

VectorY Therapeutics, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of muscular and neurodegenerative disorders through vectorized antibodies, announces the completion of a €31 million seed financing round.

AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, announced the appointment of Martijn Negen, MSc, MBA, as Vice President for Commercial Strategy.

RepliCel Life Sciences Inc., a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce it has appointed Gary Boddington to the board of directors.